The following table shows the list of Horizon 2020 projects developed by "TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | DO-IT | H2020-EU.3.1.7. | participant | 231˙190.00 | 2017-02-01 | 1014 |
2 | PERMIT | H2020-EU.3.1.6. | participant | 57˙500.00 | 2020-01-01 | 270 |
3 | IDEA-FAST | H2020-EU.3.1.7. | participant | 460˙000.00 | 2019-11-01 | 315 |
totale | 748˙690.00 |
This organization collaborated with partners in 19 countries.
Within the project DO-IT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project PERMIT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | UPDescartes | UNIVERSITE DE PARIS (HES) |
participant | NL | EATRIS | EATRIS ERIC (REC) |
coordinator | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
participant | ES | PSSJD | PARC SANITARI SANT JOAN DE DEU (OTH) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | ES | ISCIII | INSTITUTO DE SALUD CARLOS III (REC) |
participant | IT | IRFMN | ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (REC) |
participant | FR | UPDescartes | UNIVERSITE PARIS DESCARTES (HES) |
participant | LU | UdL | UNIVERSITE DU LUXEMBOURG (HES) |
participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
participant | DE | DLR | DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV (REC) |
Within the project IDEA-FAST this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | MBS | MEDIBIOSENSE LTD (PRC) |
participant | BE | BYTE | BYTEFLIES (PRC) |
participant | PT | FC.ID | FCIENCIAS.ID - ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS (REC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | IT | PLUR | PLURIBUS ONE SRL (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | BE | EFCCA | EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (OTH) |
participant | FI | VTT | Teknologian tutkimuskeskus VTT Oy (REC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | DE | GHI | GEORGE-HUNTINGTON-INSTITUT GMBH (PRC) |
participant | US | ABBV | ABBVIE INC (PRC) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | PUK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | FR | LIXOFT | LIXOFT SAS (PRC) |
participant | ES | APM | ASOCIACION PARKINSON MADRID (OTH) |
participant | NL | McR | MCROBERTS BV (PRC) |
participant | UK | TAK | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | CCL | CAMBRIDGE COGNITION LIMITED (PRC) |
participant | NO | SUH | HELSE STAVANGER HF (OTH) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | PL | IPIN | INSTYTUT PSYCHIATRII I NEUROLOGII (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | DE | EMP | EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH (PRC) |
participant | IE | UL | UNIVERSITY OF LIMERICK (HES) |
participant | PT | IMM | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (REC) |
participant | DE | UKSH | UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | FR | IMT | INSTITUT MINES-TELECOM (HES) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | ES | UAM | UNIVERSIDAD AUTONOMA DE MADRID (HES) |
participant | IT | UNIBS | UNIVERSITA DEGLI STUDI DI BRESCIA (HES) |
participant | UK | UoM | THE UNIVERSITY OF MANCHESTER (HES) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | UK | UGLAS | UNIVERSITY OF GLASGOW (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | UK | ICL | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |